Fili-Pharma SRL
Fili-Pharma reported total assets of €1.24m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jan 2026).
By total assets for 2025, Fili-Pharma ranks among the 200 largest of the 761 companies in its sector (NACE 7722) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Fili-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +62 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fili-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 140,905 € | ||||
| Equity | 968,090 € | ||||
| Cash | 339,641 € | ||||
| EBITDA | 101,271 € | ||||
| Total assets | €1.24m |
Filed annual accounts
- Year ended 30 Jun 2025filed on 29 Jan 2026
- Year ended 30 Jun 2024filed on 27 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
- Year ended 30 Jun 2021filed on 28 Jan 2022
Fili-Pharma's financial analysis
- Solvency78.0%sector median: 36.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fili-Pharma
Fili-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0822.645.914
- VAT number
- BE0822645914
- Peppol
- Registered · 0208:0822645914 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jan 2010
- Registered office
- 9406 Ninove
- Latest accounts
- 2025 · filed on 29 Jan 2026
- Activity
- Rental and leasing of medical and paramedical equipment (NACE 77225)
Fili-Pharma (SRL) has been based in Ninove since 2010, active in: rental and leasing of medical and paramedical equipment. For 2025, it reports a net profit of 140,905 € and equity of 968,090 €; its revenue is not published. Its solvency stands at 78.0%, above the median of its sector (36.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Fili-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Oftahils Wholesale of pharmaceutical and medical goods Galmaarden · balance sheet €1.61m
- LaZI-RUSh Manufacture of medical and dental instruments and supplies Aalter · balance sheet 610,303 €
- Business Executive Service Company Rental and leasing of other personal and household goods Genappe · balance sheet 74,585 €
- Meditron Wholesale of pharmaceutical and medical goods Sint-Gillis-Waas · balance sheet 488,085 €
- Oncoderma Rental and leasing of other personal and household goods Waterloo · balance sheet 5,285 €
- Laboratoire Cardio Contact Benelux Rental and leasing of other personal and household goods Uccle · balance sheet 955,974 €
- Labab Wholesale of pharmaceutical and medical goods Charleroi · balance sheet €1.27m
- InnoVentiv Europe Wholesale of pharmaceutical and medical goods Berchem-Sainte-Agathe · balance sheet 562,964 €
Frequently asked questions about Fili-Pharma
What is the revenue of Fili-Pharma?
Fili-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fili-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0822645914 for Fili-Pharma, if the company is VAT-registered. Its company number (CBE) is 0822.645.914.
Where is the registered office of Fili-Pharma?
According to the CBE register, the registered office of Fili-Pharma is in 9406 Ninove.
What is the equity of Fili-Pharma?
At the close of the 2025 financial year, the equity of Fili-Pharma amounts to 968,090 €, a solvency of 78.0% of total assets.
Who manages Fili-Pharma?
The register lists 1 active mandates at Fili-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Fili-Pharma within its sector?
By total assets for 2025, Fili-Pharma ranks among the 200 largest of the 761 companies in its sector (NACE 7722) in Belgium that filed accounts for that financial year.
The full file of Fili-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →